0001213900-21-038633.txt : 20210726 0001213900-21-038633.hdr.sgml : 20210726 20210726161532 ACCESSION NUMBER: 0001213900-21-038633 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210715 FILED AS OF DATE: 20210726 DATE AS OF CHANGE: 20210726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gupta Shalabh K. CENTRAL INDEX KEY: 0001864917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 211114314 MAIL ADDRESS: STREET 1: UNICYCIVE THERAPEUTICS, INC. STREET 2: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2021-07-15 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001864917 Gupta Shalabh K. C/O UNICYCIVE THERAPEUTICS LOS ALTOS CA 94022 1 1 0 0 CEO Stock Options 5.00 2021-07-15 4 A 0 116279 0 A 2031-07-15 Common Stock 116279 218023 D The stock options vest equally over a period of three years from the date of grant. /s/ Shalabh Gupta 2021-07-26